Vectors for molecule delivery to CD11b expressing cells

The invention relates to a novel use of a Bordetella adenylcyclase toxin in the manufacturing of vectors for targeting in vivo a molecule of interest, specifically to CD11b expressing cells. The invention also relates to an immunogenic composition that primes immune responses, to pharmaceutical comp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BAUCHE CECILE, LECLERC CLAUDE, KHELEF NADIA, EL-AZAMI EL-IDRISSI MOHAMMED, LADANT DANIEL, GUISO NICOLE, FAYOLLE CATHERINE, GUERMONPREZ PIERRE
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator BAUCHE CECILE
LECLERC CLAUDE
KHELEF NADIA
EL-AZAMI EL-IDRISSI MOHAMMED
LADANT DANIEL
GUISO NICOLE
FAYOLLE CATHERINE
GUERMONPREZ PIERRE
description The invention relates to a novel use of a Bordetella adenylcyclase toxin in the manufacturing of vectors for targeting in vivo a molecule of interest, specifically to CD11b expressing cells. The invention also relates to an immunogenic composition that primes immune responses, to pharmaceutical compositions and to a new vector for molecule delivery to CD11b expressing cells.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US9370564B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US9370564B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US9370564B23</originalsourceid><addsrcrecordid>eNrjZDAPS00uyS8qVkjLL1LIzc9JTS7NSVVISc3JLEstqlQoyVdwdjE0TFJIrSgoSi0uzsxLV0hOzckp5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8aHBlsbmBqZmJk5GxkQoAQBOqS1E</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Vectors for molecule delivery to CD11b expressing cells</title><source>esp@cenet</source><creator>BAUCHE CECILE ; LECLERC CLAUDE ; KHELEF NADIA ; EL-AZAMI EL-IDRISSI MOHAMMED ; LADANT DANIEL ; GUISO NICOLE ; FAYOLLE CATHERINE ; GUERMONPREZ PIERRE</creator><creatorcontrib>BAUCHE CECILE ; LECLERC CLAUDE ; KHELEF NADIA ; EL-AZAMI EL-IDRISSI MOHAMMED ; LADANT DANIEL ; GUISO NICOLE ; FAYOLLE CATHERINE ; GUERMONPREZ PIERRE</creatorcontrib><description>The invention relates to a novel use of a Bordetella adenylcyclase toxin in the manufacturing of vectors for targeting in vivo a molecule of interest, specifically to CD11b expressing cells. The invention also relates to an immunogenic composition that primes immune responses, to pharmaceutical compositions and to a new vector for molecule delivery to CD11b expressing cells.</description><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160621&amp;DB=EPODOC&amp;CC=US&amp;NR=9370564B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160621&amp;DB=EPODOC&amp;CC=US&amp;NR=9370564B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BAUCHE CECILE</creatorcontrib><creatorcontrib>LECLERC CLAUDE</creatorcontrib><creatorcontrib>KHELEF NADIA</creatorcontrib><creatorcontrib>EL-AZAMI EL-IDRISSI MOHAMMED</creatorcontrib><creatorcontrib>LADANT DANIEL</creatorcontrib><creatorcontrib>GUISO NICOLE</creatorcontrib><creatorcontrib>FAYOLLE CATHERINE</creatorcontrib><creatorcontrib>GUERMONPREZ PIERRE</creatorcontrib><title>Vectors for molecule delivery to CD11b expressing cells</title><description>The invention relates to a novel use of a Bordetella adenylcyclase toxin in the manufacturing of vectors for targeting in vivo a molecule of interest, specifically to CD11b expressing cells. The invention also relates to an immunogenic composition that primes immune responses, to pharmaceutical compositions and to a new vector for molecule delivery to CD11b expressing cells.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAPS00uyS8qVkjLL1LIzc9JTS7NSVVISc3JLEstqlQoyVdwdjE0TFJIrSgoSi0uzsxLV0hOzckp5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8aHBlsbmBqZmJk5GxkQoAQBOqS1E</recordid><startdate>20160621</startdate><enddate>20160621</enddate><creator>BAUCHE CECILE</creator><creator>LECLERC CLAUDE</creator><creator>KHELEF NADIA</creator><creator>EL-AZAMI EL-IDRISSI MOHAMMED</creator><creator>LADANT DANIEL</creator><creator>GUISO NICOLE</creator><creator>FAYOLLE CATHERINE</creator><creator>GUERMONPREZ PIERRE</creator><scope>EVB</scope></search><sort><creationdate>20160621</creationdate><title>Vectors for molecule delivery to CD11b expressing cells</title><author>BAUCHE CECILE ; LECLERC CLAUDE ; KHELEF NADIA ; EL-AZAMI EL-IDRISSI MOHAMMED ; LADANT DANIEL ; GUISO NICOLE ; FAYOLLE CATHERINE ; GUERMONPREZ PIERRE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US9370564B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2016</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>BAUCHE CECILE</creatorcontrib><creatorcontrib>LECLERC CLAUDE</creatorcontrib><creatorcontrib>KHELEF NADIA</creatorcontrib><creatorcontrib>EL-AZAMI EL-IDRISSI MOHAMMED</creatorcontrib><creatorcontrib>LADANT DANIEL</creatorcontrib><creatorcontrib>GUISO NICOLE</creatorcontrib><creatorcontrib>FAYOLLE CATHERINE</creatorcontrib><creatorcontrib>GUERMONPREZ PIERRE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BAUCHE CECILE</au><au>LECLERC CLAUDE</au><au>KHELEF NADIA</au><au>EL-AZAMI EL-IDRISSI MOHAMMED</au><au>LADANT DANIEL</au><au>GUISO NICOLE</au><au>FAYOLLE CATHERINE</au><au>GUERMONPREZ PIERRE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Vectors for molecule delivery to CD11b expressing cells</title><date>2016-06-21</date><risdate>2016</risdate><abstract>The invention relates to a novel use of a Bordetella adenylcyclase toxin in the manufacturing of vectors for targeting in vivo a molecule of interest, specifically to CD11b expressing cells. The invention also relates to an immunogenic composition that primes immune responses, to pharmaceutical compositions and to a new vector for molecule delivery to CD11b expressing cells.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US9370564B2
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
title Vectors for molecule delivery to CD11b expressing cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T11%3A17%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BAUCHE%20CECILE&rft.date=2016-06-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS9370564B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true